Filter
1018
Filtered Results: 1018
Text search:
immune
suppression
Featured
Recommendations
130
New Publications
243
Language
Document type
No document type
602
Guidelines
202
Studies & Reports
128
Manuals
28
Fact sheets
22
Training Material
13
Strategic & Response Plan
9
Infographics
6
Situation Updates
4
Brochures
2
Resource Platforms
1
Online Courses
1
Countries / Regions
India
67
Kenya
36
South Africa
33
Germany
24
Global
21
Africa
19
Tanzania
18
Ethiopia
17
Malawi
16
Zambia
16
Western and Central Europe
14
Uganda
14
Nepal
13
Nigeria
13
Latin America and the Carribbean
12
Zimbabwe
9
Philippines
9
Bangladesh
9
Namibia
9
Myanmar / Burma
9
Ghana
8
Sierra Leone
8
South–East Asia Region
7
Rwanda
6
Asia
6
Brazil
6
Eswatini/ Swaziland
6
Ukraine
5
Cambodia
5
Congo, Democratic Republic of
5
Lesotho
4
Burkina Faso
4
Russia
4
Cameroon
3
Albania
3
Mozambique
3
USA
3
West and Central Africa
3
Middle East and North Africa
3
Eastern Europe and Central Asia
3
East and Southern Africa
3
Botswana
3
Liberia
3
Timor Leste/ East Timor
2
Thailand
2
Benin
2
Senegal
2
Paraguay
2
Belgium
2
France
2
Eastern Europe
2
Georgia
2
Indonesia
2
Madagascar
2
North Korea
1
Switzerland
1
Colombia
1
Turkey
1
Gambia
1
Togo
1
China
1
Syria
1
Canada
1
Estonia
1
Congo-Brazzaville
1
Niger
1
Burundi
1
Peru
1
Armenia
1
Haiti
1
Venezuela
1
Luxembourg
1
Southern Africa
1
Côte d’Ivoire / Ivory Coast
1
Argentina
1
Vietnam
1
Sri Lanka
1
Djibouti
1
Sudan
1
Yemen
1
Mali
1
Angola
1
Bhutan
1
Somalia
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Countries
347
Clinical Guidelines
138
Public Health
42
Women & Child Health
23
Key Resources
19
Capacity Building
13
Pharmacy & Technologies
7
Annual Report MEDBOX
1
Toolboxes
HIV
263
TB
122
COVID-19
107
NTDs
40
Rapid Response
35
AMR
24
Refugee
15
Mental Health
14
Planetary Health
12
Pharmacy
11
NCDs
10
Caregiver
9
Ebola & Marburg
8
Malaria
7
Specific Hazards
4
Polio
4
Natural Hazards
3
Health Financing Toolbox
3
Disability
2
Cholera
2
Conflict
2
Zika
2
Global Health Education
2
2nd edition. These guidelines include several notable changes from the first edition. For cutaneous leishmaniasis, ketoconazole has been removed from the list of treatment options; the number of Leishmania species for which there is strong evidence for the efficacy of miltefosine has increased from ...
PLOS ONE | https://doi.org/10.1371/journal.pone.0196380 May 15, 2018
13 July 2021. Eid al Adha is a festival during which Muslim families and friends unite to pray together and give alms, especially in the form of sacrificed animal meat. In light of the COVID-19 pandemic, this document highlights public health advice for social gatherings and religious practices that...
Non-communicable diseases (NCDs) are the second common cause of death in sub-Saharan Africa (SSA) accounting for about 35% of all deaths, after a composite of communicable, maternal, neonatal, and nutritional diseases. Despite prior perception of low NCDs mortality rates, current evidence suggests t...
Research
Emerging Infectious Diseases Vol. 12, No. 5, May 2006
The main aim of these guidelines is to enable the central units of national TB and HIV/AIDS programmes to support districts to plan, coordinate and implement collaborative TB/HIV activities. These guidelines reinforce current medical understanding, that highly active antiretroviral treatment (HAART)...
Standard Treatment Guideline
5th revised edition.
This document provides a ranking of medically important antimicrobials for risk management of antimicrobial resistance due to non-human use. The current revision took place at the seventh meeting of the AGISAR held in Raleigh, United States of America in 2016.
Published:February 02, 2021DOI:https://doi.org/10.1016/S0140-6736(21)00234-8
The WHO COVID-19 Clinical management: living guidance contains the most up-to-date recommendations for the clinical management of people with COVID-19. Providing guidance that is comprehensive and holistic for the optimal care of COVID-19 patients throughout their entire illness is important.
The Committee discussed the implications for preparedness for smallpox-like events reflected by the ongoing COVID-19 pandemic. The Committee noted how quickly diagnostics and vaccines could be developed and deployed when resources and political will were abundant. This rapidity was also due to the f...
Addressing comorbidities and risk factors for tuberculosis (TB) is a crucial component of the World Health Organization (WHO)’s End TB Strategy. This WHO operational handbook on tuberculosis. Module 6: tuberculosis and comorbidities aims to support countries in scaling up people-centred care, ...
Interim Guidance.
A number of medical problems have been reported in survivors, including mental health issues. Ebola virus may persist in some body fluids, including semen. Ebola survivors need comprehensive support for the medical and psychosocial challenges they face and also to minimize the ...
A number of medical problems have been reported in survivors, including mental health issues. Ebola virus may persist in some body fluids, including semen. Ebola survivors need comprehensive support for the medical and psychosocial challenges they face and also to minimize the ...
This pocket guide offers basic information needed for the medical management of victims of radiation incidents in an easy-to-understand manner.
COVID-19 infection affects all age groups including newborns, however, literature is scarce on the fetal and neonatal outcomes of babies exposed in-utero, especially in Africa. The objectiveof this study was to document the perinatal outcomes of COVID-19 pregnancies and del...
The Updated guidelines on Management of tuberculosis in children and adolescents include new recommendations that cover diagnostic approaches for TB, shorter treatment for children with non-severe drug-susceptible TB, a new option for the treatment of TB meningitis, the use of bedaquiline and delama...
Selection and Use of Essential Medicines 2021
recommended
The 23rd meeting of the WHO Expert Committee on Selection and Use of Essential Medicines was coordinated from Geneva, Switzerland, and held virtually from 21 June to 2 July 2021. The Committee considered 88 applications proposing additions, changes and deletions of medicines, medicine classes and fo...
